Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer
Clinical trial NCT01345175 · COMPLETED
Trial details
- NCT number
- NCT01345175
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-26
- Primary completion
- 2023-03-23
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.